Research Article

Quality of Sulfadoxine-Pyrimethamine Given as Antimalarial Prophylaxis in Pregnant Women in Selected Health Facilities in Central Region of Ghana

Table 4

Recorded peak responses of five replicate injections and calculated percentage dissolution of sulfadoxine and pyrimethamine in Drugs I and III.

Average peak area of sulfadoxine (mV)Percentage of sulfadoxine dissolved (%)Average peak area of pyrimethamine (mV)Percentage of pyrimethamine dissolved (%)

Drug I
 1689277459.429018220.20
 2707677961.0011485225.74
 3699109260.279066720.31
 4701723260.4910568223.67
 5698154660.1811056324.76
 6688957559.3911547225.86
Drug III
 11089813093.94358382.580.27
 21051624190.6534735777.80
 31079060893.0230503568.32
 41081192493.20314093.570.35
 51067933892.06298327.666.82
 61059261191.31306223.368.59

(mV): millivolts.